XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. is a blank check company formed to pursue an acquisition in the pharmaceutical and life sciences sector. The company went public in 2017 and filed a Form 10-Q with the Securities and Exchange Commission in May 2018, reflecting its status as an active shell company in the pre-combination phase. Operating under CIK 0001697805, Xynomic targeted the healthcare and biopharmaceutical industry, a sector that drew considerable SPAC attention during the 2017-2018 wave of blank check issuances. The company's filing record indicates ongoing reporting obligations consistent with an exchange-listed SPAC. For complete filing history, deal timeline, and sponsor details on Xynomic Pharmaceuticals Holdings, sign up for full data access at SpacDesk.